Pharming Group N.V. (PHAR) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 295.51M | 299.38M | 236.46M | 245.78M | 214.11M | 278.44M | 282.19M | 252.63M | 274.81M | 316.34M | 275.95M | 255.28M |
| Cash & Short-Term Investments | 170.9M | 179.81M | 141.54M | 128.73M | 107.27M | 167.89M | 171.77M | 149.66M | 187.17M | 213.42M | 186.88M | 176.29M |
| Cash Only | 53.1M | 146.02M | 112.75M | 94.82M | 60.09M | 54.94M | 60.66M | 44.01M | 48.09M | 61.74M | 51.7M | 176.29M |
| Short-Term Investments | 117.8M | 33.79M | 28.79M | 33.92M | 47.18M | 112.95M | 111.1M | 105.65M | 139.08M | 151.68M | 135.18M | 0 |
| Accounts Receivable | 60.03M | 54.69M | 37.14M | 53.33M | 47.49M | 50.17M | 48.2M | 47.72M | 35.86M | 42.62M | 38.33M | 30.39M |
| Days Sales Outstanding | 71 | 0.04 | 42.78 | 49.21 | 55.56 | 48.83 | 58.95 | 51.37 | 64.24 | 45.85 | 47.42 | 50.35 |
| Inventory | 64.58M | 64.88M | 57.19M | 63.72M | 59.35M | 55.72M | 62.23M | 55.25M | 51.79M | 56.76M | 50.55M | 48.61M |
| Days Inventory Outstanding | 873.65 | 0.27 | 786.52 | 624.08 | 622.15 | 444.26 | 792.51 | 609.36 | 588.94 | 693.48 | 549.87 | 739.06 |
| Other Current Assets | 0 | 1K | 587.74K | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 200.53K | 1 |
| Total Non-Current Assets | 193.85M | 200.43M | 167.11M | 200.48M | 189.07M | 121.55M | 143.32M | 135.63M | 134.48M | 146.51M | 136.9M | 138.59M |
| Property, Plant & Equipment | 23.1M | 23.96M | 21.29M | 24.57M | 24.23M | 24.13M | 30.67M | 28.68M | 29.53M | 33.47M | 35.45M | 36.06M |
| Fixed Asset Turnover | 3.09x | 4706.99x | 4.24x | 3.82x | 3.27x | 3.38x | 2.52x | 2.54x | 1.76x | 2.36x | 1.86x | 1.49x |
| Goodwill | 0 | 135.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 130.99M | 0 | 114.93M | 135.9M | 138.86M | 61.04M | 67.1M | 62.14M | 63.29M | 71.27M | 66.07M | 67.28M |
| Long-Term Investments | 9.01M | 9.87M | 5.68M | 8.72M | 5.92M | 4.23M | 8.71M | 6.87M | 7.12M | 10.4M | 8.74M | 8.84M |
| Other Non-Current Assets | 92K | 93.97K | 25.21M | 95K | 1.67M | 1.59M | 93K | 37.93M | 34.54M | 1.62M | 26.64M | 26.41M |
| Total Assets | 489.37M | 499.81M | 403.57M | 446.26M | 403.18M | 399.99M | 425.51M | 388.27M | 409.29M | 462.85M | 412.85M | 393.87M |
| Asset Turnover | 0.15x | 235.78x | 0.23x | 0.22x | 0.20x | 0.22x | 0.18x | 0.19x | 0.13x | 0.19x | 0.17x | 0.14x |
| Asset Growth % | 21.38% | 24.96% | -5.16% | 14.94% | -1.49% | -13.58% | 3.07% | -1.42% | 4.96% | 8.7% | 5.82% | 4.76% |
| Total Current Liabilities | 112.35M | 115.79M | 74.89M | 87.94M | 77.54M | 73.8M | 79.84M | 74.62M | 192.09M | 77.97M | 64.38M | 59.52M |
| Accounts Payable | 103.53M | 105.87M | 66.63M | 78.38M | 68.75M | 10.1M | 72.64M | 68.11M | 63.49M | 16.02M | 59.16M | 54.34M |
| Days Payables Outstanding | 1.41K | 0.38 | 943.36 | 746.15 | 426.32 | 311.64 | 949.5 | 749.22 | 431.43 | 485.84 | 629.41 | 822.22 |
| Short-Term Debt | 8.14M | 5.34M | 4.44M | 5.11M | 4.55M | 4.25M | 3.32M | 2.94M | 125M | 1.82M | 1.65M | 1.65M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 675K | 1.22M | -851 | 0 | 0 | 40.39M | 0 | 1 | 0 | 0 | 0 | 1 |
| Current Ratio | 2.63x | 2.59x | 3.16x | 2.79x | 2.76x | 3.77x | 3.53x | 3.39x | 1.43x | 4.06x | 4.29x | 4.29x |
| Quick Ratio | 2.06x | 2.03x | 2.39x | 2.07x | 2.00x | 3.02x | 2.76x | 2.65x | 1.16x | 3.33x | 3.50x | 3.47x |
| Cash Conversion Cycle | -468.43 | -0.07 | -114.06 | -72.86 | 251.39 | 181.45 | -98.04 | -88.49 | 221.75 | 253.48 | -32.12 | -32.8 |
| Total Non-Current Liabilities | 108.06M | 107.07M | 103.26M | 118.77M | 110.36M | 105.12M | 119.88M | 107.4M | 26.35M | 166.1M | 149.89M | 150.73M |
| Long-Term Debt | 93.39M | 92.72M | 79.33M | 91.27M | 83.85M | 78.15M | 92.1M | 81.52M | 0 | 136.6M | 122.71M | 122.97M |
| Capital Lease Obligations | 14.67M | 14.35M | 23.93M | 27.5M | 26.51M | 26.97M | 27.78M | 25.89M | 26.35M | 29.51M | 27.18M | 27.77M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | -851 | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 2 | 2 |
| Total Liabilities | 220.41M | 222.79M | 178.15M | 206.71M | 187.89M | 178.92M | 199.72M | 182.02M | 218.44M | 244.07M | 214.27M | 210.25M |
| Total Debt | 116.2M | 115.78M | 111.52M | 128.33M | 119.14M | 112.31M | 127.08M | 113.91M | 154.95M | 171.54M | 155.11M | 155.91M |
| Net Debt | 63.1M | -30.25M | -1.23M | 33.51M | 59.05M | 57.37M | 66.42M | 69.9M | 106.86M | 109.8M | 103.42M | -20.38M |
| Debt / Equity | 0.43x | 0.42x | 0.49x | 0.54x | 0.55x | 0.51x | 0.56x | 0.55x | 0.81x | 0.78x | 0.78x | 0.85x |
| Debt / EBITDA | 20.57x | 0.06x | 6.01x | 9.47x | - | 7.80x | 18.55x | - | - | 19.89x | 32.25x | 18.43x |
| Net Debt / EBITDA | 11.17x | -0.02x | -0.07x | 2.47x | - | 3.98x | 9.70x | - | - | 12.73x | 21.50x | -2.41x |
| Interest Coverage | 0.93x | 4.43x | 2.61x | 1770.75x | -1.31x | 6.35x | 1.51x | 0.97x | -9.68x | -0.15x | - | 1.45x |
| Total Equity | 268.96M | 277.02M | 225.42M | 239.55M | 215.29M | 221.06M | 225.79M | 206.24M | 190.85M | 218.78M | 198.58M | 183.62M |
| Equity Growth % | 24.93% | 25.31% | -0.16% | 16.15% | 12.81% | 1.04% | 13.7% | 12.32% | 3.85% | 6.91% | -2.83% | -3.65% |
| Book Value per Share | 3.83 | 3.66 | 3.37 | 3.58 | 3.22 | 3.25 | 3.49 | 2.43 | 2.28 | 2.61 | 2.42 | 2.79 |
| Total Shareholders' Equity | 268.96M | 277.02M | 225.42M | 239.55M | 214M | 221.06M | 225.79M | 206.24M | 190.85M | 218.78M | 198.58M | 183.62M |
| Common Stock | 8.06M | 8.01M | 6.77M | 7.82M | 7.81M | 7.77M | 7.75M | 7.23M | 7.12M | 7.67M | 7.24M | 6.91M |
| Retained Earnings | -281.45M | -272.9M | -213.82M | -286.03M | -292.8M | -275.49M | -278.37M | -255.46M | -260.77M | -265.26M | -258.88M | -248.83M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 23.75M | 0 | 0 | 25.91M | 8.69M | -209K | 9.33M | 0 | 0 | -2.06M | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 1.29M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |